Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Korea Stock Exchange  >  Celltrion, Inc.    A068270   KR7068270008

CELLTRION, INC.

(A068270)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
02/18/2021 02/19/2021 02/22/2021 02/23/2021 02/24/2021 Date
314500 318500 309500 296000 282000 Last
671084 855583 725100 1261921 1494863 Volume
-2.18% +1.27% -2.83% -4.36% -4.73% Change
Financials
Sales 2020 1 860 B 1,68 B 1,68 B
Net income 2020 576 B 0,52 B 0,52 B
Net cash position 2020 480 B 0,43 B 0,43 B
P/E ratio 2020 66,4x
Yield 2020 0,00%
Sales 2021 2 243 B 2,02 B 2,02 B
Net income 2021 765 B 0,69 B 0,69 B
Net cash position 2021 757 B 0,68 B 0,68 B
P/E ratio 2021 51,0x
Yield 2021 0,00%
Capitalization 38 482 B 34 686 M 34 711 M
EV / Sales 2020 20,4x
EV / Sales 2021 16,8x
Nbr of Employees 908
Free-Float 66,4%
More Financials
Company
Celltrion, Inc. is a Korea-based company mainly engaged in the production and sale of biopharmaceuticals. Along with subsidiaries, the Company operates its business through three segments. The Biopharmaceutical segment is involved in the manufacturing and sale of biopharmaceutical products such as multivitamins, blood circulation remedies, blood cancer treatments and breast cancer treatments. The Chemical... 
More about the company
Notations Surperformance© of Celltrion, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about CELLTRION, INC.
02/05Enthusiasm Fades for Covid-19 Antibody Treatments in South Korea
DJ
02/03S.Korea regulator extends ban on short-selling of stocks to May 2
RE
02/01S.Korea shares jumps most in 3 wks on upbeat trade data, fading volatility wo..
RE
02/01Reddit-inspired retail swarm in South Korea battle to remove short sell polic..
RE
01/19S.Korean stocks see best day in over a week on Samsung Elec, Hyundai Motor bo..
RE
01/05S.Korea shares end at record high on robust chip outlook
RE
2020CELLTRION HEALTHCARE : Seeks South Korean Approval for Emergency Use of Covid-19..
DJ
2020S.Korea shares end at record high on biopharmaceuticals boost
RE
2020KOSPI COMPOSITE INDEX : Seoul Stocks End Higher on Hopes over COVID-19 Vaccines
MT
2020S.Korean stocks touch record high on Samsung Elec, SK Hynix boost
RE
2020S.Korea shares close at record high on chip, auto boost
RE
2020North Korea-linked hackers targeted J&J, Novavax in hunt for COVID research
RE
2020North Korean Hackers Are Said to Have Targeted Companies Working on Covid-19 ..
DJ
2020North Korean Hackers Are Said to Have Targeted Companies Working on Covid-19 ..
DJ
2020CELLTRION : Phase II trial to study anti-COVID-19 mAb CT-P59 completes enrolment
AQ
More news
News in other languages on CELLTRION, INC.
02/05MÄRKTE ASIEN/Freundlicher Wochenausklang - Spektakuläres Debüt in Hongkong
02/05MÄRKTE ASIEN/Börsen zurück in Erfolgsspur - Spektakuläres Debüt in Hongkong
02/01UPDATE/MÄRKTE ASIEN/Wieder erwachte Impfzuversicht sorgt für Kauflaune
2020MÄRKTE ASIEN/Nikkei macht 2,7%-Satz auf 30-Jahres-Hoch
2020MÄRKTE ASIEN/Nikkei mit kräftigem Satz auf 30-Jahres-Hoch
More news
Analyst Recommendations on CELLTRION, INC.
More recommendations
Chart CELLTRION, INC.
Duration : Period :
Celltrion, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CELLTRION, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 322 849,33 KRW
Last Close Price 282 000,00 KRW
Spread / Highest target 56,4%
Spread / Average Target 14,5%
Spread / Lowest Target -53,9%
EPS Revisions
Managers and Directors
NameTitle
Wu-Sung Ki Chief Executive Officer & Director
Ho-Seop Lee Finance Director
Jung-Jin Seo Chairman
Sung-Han Lee Head-Legal & Compliance Support
Dong-Il Kim Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CELLTRION, INC.-21.45%34 686
MODERNA, INC.38.59%57 295
LONZA GROUP AG4.15%48 455
IQVIA HOLDINGS INC.8.61%37 221
SEAGEN INC.-11.49%28 084
HANGZHOU TIGERMED CONSULTING CO.,LTD-5.39%20 223